Membership

Chair

Walter J. Koroshetz, MD, Chair

Director
National Institute of Neurological Disorders and Stroke

Bethesda, MD
07/31/2021

Read More

Dr. Koroshetz became the Director of NINDS in June, 2015. Previously, he served as Acting Director beginning October, 2014 and Deputy Director of NINDS under Dr. Story Landis. Together, they directed program planning and budgeting, and oversaw the scientific and administrative functions of the Institute. He has held leadership roles in a number of NIH and NINDS programs including the NIH’s BRAIN Initiative, the Traumatic Brain Injury Center collaborative effort between the NIH intramural program and the Uniformed Health Services University, and the multi-year work to develop and establish the NIH Office of Emergency Care Research to coordinate NIH emergency care research and research training.

Before joining NINDS, Dr. Koroshetz served as Vice Chair of the neurology service and Director of stroke and neurointensive care services at Massachusetts General Hospital (MGH). He was a professor of Neurology at Harvard Medical School (HMS) and led neurology resident training at MGH between 1990 and 2007. Over that same period, he co-directed the HMS Neurobiology of Disease Course with Drs. Edward Kravitz and Robert H Brown.

A native of Brooklyn, New York, Dr. Koroshetz graduated from Georgetown University and received his medical degree from the University of Chicago. He trained in internal medicine at the University of Chicago and Massachusetts General Hospital. Dr. Koroshetz trained in neurology at MGH, after which he did post-doctoral studies in cellular neurophysiology at MGH with Dr. David Corey, and later at the Harvard neurobiology department with Dr. Edward Furshpan, studying mechanisms of excitoxicity and neuroprotection. He joined the neurology staff, first in the Huntington’s Disease (HD) unit, followed by the stroke and neurointensive care service. A major focus of his clinical research career was to develop measures in patients that reflect the underlying biology of their conditions. With the MGH team he discovered increased brain lactate in HD patients using MR spectroscopy. He helped the team to pioneer the use of diffusion/perfusion-weighted MR imaging and CT angiography/perfusion imaging in acute stroke.

Active in the American Academy of Neurology (AAN), Dr. Koroshetz chaired the professional organization’s Public Information Committee, led the AAN’s efforts to establish acute stroke therapy in the US, founded the Stroke Systems Working Group, and was a member of the AAN Board of Directors.

Federal Members

Col. Chester “Trip” Buckenmaier, III, MD

Director, Defense and Veterans Center for Integrative Pain Management
Walter Reed National Military Medical Center
Washington, DC
07/31/2021

Read More

Colonel Chester “Trip” Buckenmaier III is the current Director of the Defense and Veterans Center for Integrative Pain Management and Fellowship Director of the Acute Pain Medicine and Regional Anesthesia program at Walter Reed National Military Medical Center in Washington DC. He is an Associate Professor in Anesthesiology at the Uniformed Services University of the Health Sciences and a Diplomat, with the American Board of Anesthesiology. He attended Catawba College, on a Reserve Officers' Training Corps (ROTC) scholarship, graduating with a degree in Biology and Chemistry in 1986. He then attended East Carolina University in Greenville, N.C., receiving a Master in Science in Biology in 1988. In 1992, he graduated from the Uniformed Services University of the Health Sciences in Bethesda, Maryland, completing his Anesthesia Residency at Walter Reed. In addition, he completed a one year Fellowship in Regional Anesthesia at Duke University in 2002, resulting in the creation of the only Acute Pain Medicine Fellowship in the American military at Walter Reed. In September 2003, he deployed with the 21st Combat Support Hospital to Balad, Iraq, and demonstrated that the use of advanced regional anesthesia can be accomplished in a forward deployed environment. He performed the first successful continuous peripheral nerve block for pain management in a combat support hospital. In April 2009, he deployed to Camp Bastion, Afghanistan with the British military and ran the first acute pain service in a theatre of war.

David Clark, MD

Director
Palo Alto VA Pain Management Service

Palo Alto, CA
07/31/2021

Read More

David J. Clark, MD, is Director of the Palo Alto VA Pain Management Service, and directs a laboratory whose interests are focused on understanding pain mechanisms as well as developing new treatments.

Charles G. Helmick III, MD

Senior Medical Epidemiologist
Centers for Disease Control and Prevention

07/31/2021

Read More

Dr. Helmick is a senior medical epidemiologist with the Arthritis Program at the National Center for Chronic Disease Prevention and Health Promotion, part of the Centers for Disease Control and Prevention. His current responsibilities include directing the team’s scientific staff and resources to implement the surveillance, epidemiology, and prevention research strategies laid out in the National Arthritis Action Plan which he helped to write. He is also a Workgroup Coordinator as well as author of the first-ever Healthy People 2010 arthritis objectives. Dr. Helmick has nearly 29 years of experience in public health, working first on infectious disease issues as part of the Epidemic Intelligence Service training program at CDC, then on international public health issues at the Sierra Leone Caribbean Epidemiology Centre, followed by 24 years at CDC working on chronic disease problems, including multiple sclerosis, digestive diseases, and age-related disorders. Dr. Helmick received his undergraduate degree in Zoology from the University of Michigan and medical degree from Johns Hopkins School of Medicine. He has authored or co-authored over 100 articles in peer-reviewed journals and has received several awards for scientific work in public health and government service.

Elizabeth Kato, MD, MRP

Medical Officer at the Center for Evidence and Practice Improvement
Agency for Healthcare Research and Quality

07/31/2022

Read More

Dr. Elisabeth Kato is a Medical Officer at the Center for Evidence and Practice Improvement at the Agency for Healthcare Research and Quality (AHRQ). As Medical Officer, she coordinates opioid-related activities across AHRQ, including chairing opioid workgroup meetings, internal and external reporting, and representing AHRQ on intergovernmental working groups and conferences.

Scientific Members

Daniel B. Carr, MD

Professor
Tufts University School of Medicine

07/31/2021

Read More

Dr. Carr is a Professor at Tufts University School of Medicine and directs its interprofessional program in Pain Research, Education and Policy, the only such program based in a department of public health and community medicine. A clinician and investigator, he has published in pain research, evidence-based medicine, and the social and political aspects of pain relief. He was Founding Editor of IASP’s Pain: Clinical Updates, co-founding editor for pain trials in the Cochrane review group on Pain, Palliative and Supportive Care, and serves on editorial boards of pain-related journals. Key publications include co-editing the first two DHHS clinical practice guidelines on pain; the first monograph on evidence, outcomes and quality of life in pain management; and the latest edition of the authoritative Cousins and Bridenbaugh text on neural blockade and pain medicine. Beyond his work with IASP and the US AHCPR and AHRQ, he has had advisory roles for the American Society of Anesthesiologists, the American Academy of Pain Medicine, the American Pain Society, the Interstitial Cystitis Association, the Phoenix Society for Burn Survivors the Joint Commission, NIH, FDA, and the American Chronic Pain Association. He holds 20 analgesia-related patents. His honors include ASRA’s Bonica Lecture, APS’s Fordyce, Distinguished Service, and Narcessian (Educational Excellence) Awards, AAPM’s Lippe and Founders’ Awards, and two citations from the Secretary of HHS.

Beth Darnall, PhD

Professor
Stanford University School of Medicine

07/31/2022

Read More

Dr. Beth Denise Darnall is a Professor in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine. In 2019, she became Chief Science Officer at AppliedVR, a digital health company. She is a pain psychologist and scientist, international speaker, and respected author. Her primary interest is helping people with chronic pain to optimize their mind-body connection to reduce their own symptoms, improve health and function, and enhance response to medical treatments (placebo response).

Christine Goertz, PhD

Chief Executive Officer
Spine Institute for Quality

07/31/2022

Read More

Dr. Christine Marie Goertz is the Chief Executive Officer of the Spine Institute for Quality. She is also Vice Chairperson at the Patient Centered Outcomes Research Institute and serves on their Board of Governors. She is also President of Christine Goertz LLC and an Adjunct Associate at the Department of Orthopaedic Surgery at Duke University Medical Center. Her 25-year research career has focused on working with multidisciplinary teams to design and implement clinical and health services research studies designed to increase knowledge about the effectiveness and cost of complementary and integrative healthcare delivery. In addition, she has a long history of service on pain-related organizations. She has served on the National Advisory Council for Complementary and Integrative Health. She has also been a member of the NIH Task Force on Chronic Low Back Pain.

Robert D. Kerns, PhD

Professor of Psychiatry
Yale University

07/31/2021

Read More

Robert Kerns, PhD, is a clinical psychologist with broad clinical and health services research interests focused primarily on assessment and management of chronic pain and mental health and substance use disorder co-morbidities.

Jose A. Moron-Concepcion, PhD

Professor
Washington University

07/31/2022

Read More

Dr. Jose A. Moron-Concepcion is a Professor of Anesthesiology at the Washington University School of Medicine in St. Louis Missouri. His laboratory is interested in examining the molecular mechanisms underlying opioid dependence and the intersection with pain mechanisms. He has served on multiple national committees, including the National Academy of Sciences Advisory Committee to the FDA on improving the use of prescription opioids to treat pain.

Christine Nai-Mei Sang, MD, MPH

Associate Professor of Anesthesia
Harvard Medical School

07/31/2022

Read More

Christine Sang, MD, MPH is Associate Professor of Anaesthesia at Harvard Medical School. She is a pediatric and adult anesthesiologist and an acute post-operative/post-traumatic and chronic pain specialist. Dr. Sang is the founding director of the Translational Pain Research Program at the Brigham and Women's Hospital, where they conduct Phases 1a (First-in-Human) through 2a (proof-of-concept) clinical trials in a variety of acute/post-traumatic and chronic pain indications. Her focus is on approaches to and relevant designs for clinical translation.

David Williams, PhD

Professor of Anesthesiology, Medicine (Rheumatology), Psychiatry, and Psychology
University of Michigan

07/31/2022

Read More

Dr. David A. Williams is a Professor of Anesthesiology, Medicine, Psychiatry, and Psychology at the University of Michigan where he serves as the Associate Director of the Chronic Pain and Fatigue Research Center, Co-Director of Research Development within the Michigan Institute for Clinical and Health Research, and as a senior faculty member within the Institute of Healthcare Policy and Innovation. He is both a clinician and researcher with publications in the areas of chronic illness management, e- and m-health services delivery, patient-reported outcomes instrument development and validation, and mechanisms of pain perception/modulation. He is the immediate past President of the American Pain Society and serves on numerous scientific editorial boards and scientific review committees both nationally and internationally.

Public Members

James W. Broatch

Executive Vice President and Director
Reflex Sympathetic Dystrophy Syndrome Association

07/31/2022

Read More

Jim Broatch, MSW has served as RSDSA’s Executive Director for 15 Years and serves on RSDSA’s Board of Directors.  In addition to leading RSDSA, Mr. Broatch serves as a compassionate, knowledgeable point of contact for individuals newly diagnosed with CRPS or those suffering for decades with the intractable pain and disability caused by CRPS who reach out to RSDSA for direction.

George Carter

Administrator
Statewide Sickle Cell Chapters of Virginia

07/31/2021

Read More

George Carter suffers with Sickle Beta Zero Thalassemia.  He has been working with various sickle cell organizations for over 40 years.  He serves as a Sickle Cell Disease Patient Consultant for the Food & Drug Administration (FDA).  Currently, he primarily serves as the Administrator (unpaid Executive Director) of Statewide Sickle Cell Chapters of Virginia.

Statewide Sickle Cell Chapters of Virginia, Inc., also known as Sickle Cell Chapters of Virginia, is a non-profit 501(c)(3) tax-exempt community-based organization, that has a network of nine (9) community-based organizations (chapters) that provide a variety of services across the Commonwealth.   

George Carter’s main focus is to advocate for those who suffer from Sickle Cell Disease and distribute information about sickle cell and uplifting messages to patients.  Around 4,000 African Americans in Virginia suffer with Sickle Cell Disease and approximately 155,000 have Sickle Cell Trait.   

Under George Carter’s direction and lobbying, Statewide has received over one million dollars in funding from the State of Virginia since 2008.  The funds help several chapters provide education and assist individuals and families living with Sickle Cell to develop necessary skills and resources to improve their health status, family functioning, and self-sufficiency.

Katherine Hammitt

Vice President of Medical and Scientific Affairs
Sjogren's Syndrome Foundation

07/31/2021

Read More

Katherine Hammitt is the Vice President of Medical and Scientific affairs of the  Sjögren’s Syndrome Foundation. Additionally, she directed the international clinical trials consortium; worked with experts to develop and validate classification criteria for Sjögren’s; and oversees the Foundation’s research grants program, medical and scientific advisory board and relationships with government agencies.

Gwenn Herman

Clinical Director
Pain Connection, US Pain Foundation

07/31/2021

Read More

Gwenn Herman has been a chronic pain patient for over 23 years. Seventeen years ago she started a non-profit called Pain Connection to offer direct services to people with chronic pain. Pain Connection joined with US Pain Foundation and now Ms. Herman’s role is directing Pain Connection Programs for the US Pain Foundation.

Sue Pinkham

President of the Board of Directors
The Coalition Against Pediatric Pain

07/31/2022

Read More

Ms. Sue Pinkham is the President of the Board of Directors at The Coalition Against Pediatric Pain (TCAPP). Her duties include presiding over Board meetings, fundraising, and working to fulfill the mission of TCAPP. The TCAPP's mission is to support and unite families affected by pediatric pain, educate others regarding long-term consequences of pediatric pain, increase awareness of special needs of children affected by pediatric pain, fundraise for organizations that operate to alleviate pediatric pain, and provide resources for and funding to families and professionals affected by pediatric pain. Ms. Pinkham has a daughter who was diagnosed with CRPS/RSD in 2005 and EDS in 2012. She has been involved in raising funds and awareness of CRPS/RSD since 2008.

Irma R. Rodriguez

Chair of the Board of Directors
Interstitial Cystitis Association

07/31/2022

Read More

Ms. Irma R. Rodriguez is the Chair of the Board of Directors for the Interstitial Cystitis Association (ICA}. The ICA Board guides strategic planning and organizational direction. Board members offer support for and spur interest in programs and services and provide fiduciary oversight of organizational activities. Ms. Rodriguez is a patient and longtime supporter of the ICA and has experience with advocacy, research funding, and education in interstitial cystitis. She maintains an active leadership role in professional organizations and the community.

Ex-Officio Members

 

Nora D. Volkow, MD

Director
National Institute on Drug Abuse, National Institutes of Health

Bethesda, MD

 

Helene Langevin, MD, CM

Director
National Center for Complementary and Integrative Health

 

Shannon N. Zenk, PhD, MPH, RN, FAAN

Director
National Institute of Nursing Research

 

Rena D'Souza, DDS, MS, PhD

Director
National Institute of Dental and Craniofacial Research